Zhang et al., 2021 - Google Patents
Leisure activities, APOE ε4, and cognitive decline: a longitudinal cohort studyZhang et al., 2021
View HTML- Document ID
- 16338228034627221829
- Author
- Zhang Y
- Fu S
- Ding D
- Lutz M
- Zeng Y
- Yao Y
- Publication year
- Publication venue
- Frontiers in Aging Neuroscience
External Links
Snippet
Background: Both leisure activities and the ε4 allele of the apolipoprotein E (APOE ε4) have been shown to affect cognitive health. We aimed to determine whether engagement in leisure activities protects against APOE ε4-related cognitive decline. Methods: We used the …
- 230000000694 effects 0 title abstract description 166
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Leisure activities, APOE ε4, and cognitive decline: a longitudinal cohort study | |
Scheltens et al. | Alzheimer's disease | |
US20210341494A1 (en) | Personalized Medicine Approach for Treating Cognitive Loss | |
Friberg et al. | Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation | |
Angelopoulou et al. | APOE genotype and Alzheimer’s disease: the influence of lifestyle and environmental factors | |
Ferguson et al. | Genome-wide association study of circadian rhythmicity in 71,500 UK biobank participants and polygenic association with mood instability | |
Shadrina et al. | Varicose veins of lower extremities: Insights from the first large-scale genetic study | |
Gervil et al. | The relative role of genetic and environmental factors in migraine without aura | |
Shi et al. | Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay | |
Kravitz et al. | Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old | |
Næss et al. | Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population–results from the HUNT 2 study | |
Rajan et al. | Gene-environment interaction of body mass index and apolipoprotein E ε4 allele on cognitive decline | |
Lyall et al. | Assessing for interaction between APOE ε4, sex, and lifestyle on cognitive abilities | |
Liu et al. | Vitamin D status is an independent risk factor for global cognitive impairment in peritoneal dialysis patients | |
Feng et al. | Effects of choral singing versus health education on cognitive decline and aging: a randomized controlled trial | |
Banigbe et al. | High prevalence of undiagnosed hypertension among men in North Central Nigeria: Results from the Healthy Beginning Initiative | |
Wilson et al. | Cognitive aging and rate of hospitalization in an urban population of older people | |
Salama et al. | Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus | |
Allen et al. | Prospective study design and data analysis in UK Biobank | |
Brenowitz et al. | Extension of mendelian randomization to identify earliest manifestations of Alzheimer disease: association of genetic risk score for Alzheimer disease with lower body mass index by age 50 years | |
Vangkilde et al. | Schizophrenia spectrum disorders in a Danish 22q11. 2 deletion syndrome cohort compared to the total Danish population—a nationwide register study | |
Mirmiran et al. | The higher adherence to healthy lifestyle factors is associated with a decreased risk of metabolic syndrome in Iranian adults | |
Chen et al. | Exploration of cross-talk and pyroptosis-related gene signatures and molecular mechanisms between periodontitis and diabetes mellitus via peripheral blood mononuclear cell microarray data analysis | |
Cheema et al. | Genetic associations of PPARGC1A with type 2 diabetes: differences among populations with African origins | |
Park et al. | Modifying effects of race and ethnicity and APOE on the association of physical activity with risk of Alzheimer's disease and related dementias |